Mount Sinai researchers created a cloud-based digital framework, Employee Health COVID-19 REDCap Registry, to track employee health data and mitigate COVID-19 spread. The platform reduced case follow-up times from days to hours and helped identify occupational and non-occupational risk factors.
Researchers have developed a new therapy that uses CAR T cells to target macrophages in tumors, reducing their growth and increasing anti-tumor immunity. The treatment was shown to be effective in preclinical models of ovarian, lung, and pancreatic cancers.
A new stem cell study provides insight into how neurons from individuals with post-traumatic stress disorder (PTSD) respond to stress hormones. The research found that these cells are hypersensitive to the stress hormone hydrocortisone, which could help explain why some people develop PTSD after trauma exposure.
Researchers discovered two distinct types of regret linked to separate parts of the brain, influencing stress response and mood disorders. Stress-susceptible mice were hypersensitive to one type, while healthy mice were sensitive to another.
Researchers at Mount Sinai's Tisch Cancer Institute have discovered a new gene, PDZK1IP1, essential to colon cancer growth. The study found that surrounding inflammation activates the super enhancer, promoting tumor cell survival and growth.
A study found impairments in the prefrontal cortex-habenula circuit, critical for regulating executive functions and reward, in people with cocaine or heroin addiction. The circuit's microstructural features were analyzed using diffusion MRI tractography, revealing reduced coherence in white matter fibers.
Researchers identified TDRD7 as a key regulator against influenza A virus and found that inhibiting its function increases virus replication. The study's findings could inform the development of novel therapeutic interventions against influenza virus infection in humans.
Researchers at Mount Sinai found that COVID-19 severity is associated with a shift in macrophage populations, leading to inflammation and tissue damage. Restoring reparative lung resident macrophages may be a viable therapeutic strategy for treating SARS-CoV-2 and other inflammatory lung diseases.
The study found that a combination of NOX1, loss of function, and TNF leads to an abnormal increase in microfold cells, driving increased recruitment of immune cells. Reversing the defect with reactive oxygen species restored healthy gut balance. Further studies on reactive oxygen species-stem cell modulation therapy are proposed.
A new study finds that consistently losing an hour and a half of sleep per night can negatively impact immune stem cells, leading to increased inflammation and cardiovascular disease. Even after catching up on sleep, the effects of disrupted sleep remain long-lasting.
The study used a weakly supervised deep learning algorithm to analyze human brain autopsy tissues and predict the presence or absence of cognitive impairment. The model identified a signal associated with decreasing myelin staining, which was linked to cognitive impairment in the white matter.
Researchers discovered a type of triple-negative breast cancer cell that can trigger dormancy, evading therapies and allowing for efficient survival in distant organs. This finding highlights the need for more selective therapeutic strategies targeting both dividing and invasive dormant cells.
Valentin Fuster, MD, PhD, is honored with the TCT Career Achievement Award for his transformative work in interventional cardiology and patient care. He has made significant global contributions to cardiovascular medicine.
Bladder cancer researchers discovered a subset of CD8 T cells that adapts to tumor evasion strategies, offering a strategy to reduce tumor cells' ability to fight them off. The study also identified potential ways to make immunotherapy more effective against this deadly cancer by targeting the HLA-E/NKG2A axis.
Researchers at Mount Sinai have produced a high-resolution crystal structure of the nsp14 enzyme essential to SARS-CoV-2 survival. This discovery could lead to the design of new antivirals to combat current and future coronaviruses.
Scientists have discovered a potential path against inherited neurodegenerative diseases by increasing the activity of TRAP1, which promotes mitochondrial protein-folding and corrects lysosomal dysfunction. This approach may have implications for treating multiple disorders affecting the central nervous system.
A new study suggests that low-dose ketamine is generally safe and effective in treating clinical symptoms of children diagnosed with ADNP syndrome, a rare neurodevelopmental disorder. The treatment resulted in improvements in social behavior, attention deficit, and hyperactivity, as well as reduced aggression.
A study of NASA astronauts found DNA mutations associated with spaceflight, increasing the risk of cardiovascular disease and blood cancer. Regular screening is recommended to monitor astronaut health.
A new risk score can help predict mortality for patients with atrial fibrillation who have undergone successful TAVR and been discharged home. The risk score was developed using data from the ENVISAGE-TAVI AF trial, which found that patients with certain clinical risks were more likely to die within a year of discharge.
The SECURE trial found that the polypill, containing aspirin, ramipril, and atorvastatin, achieves clinically relevant reductions in recurrent cardiovascular events among patients recovering from a heart attack. This simplified approach improves treatment adherence, leading to a 33% reduction in cardiovascular mortality.
A new study of over 150,000 participants has identified more than 70 genes strongly associated with autism and over 250 with strong links to the condition. The analysis provides insights into the molecular roots of brain development and neurodiversity.
A comprehensive analysis of interstitial lung disease diagnosis and treatment in patients who received an antibody drug conjugate known as T-DXd found that close monitoring and proactive management can reduce the risk of ILD. The study results suggest that patient awareness and ongoing education can aid in early detection.
A team of researchers from The Mount Sinai Hospital has made a groundbreaking discovery into the genetic and molecular mechanisms that predispose individuals to Alzheimer's disease. They identified 21 candidate risk genes, including SPI1, which regulates microglia and AD risk.
A team of researchers at Mount Sinai discovered a molecular mechanism involving carbohydrate response-element binding protein (ChREBP) that plays a key role in glucose toxicity and beta-cell death. Increasing expression of an alternate form of ChREBP or activating nuclear factor-erythroid factor 2 can preserve beta-cell mass.
Researchers developed a non-invasive ocular imaging method to detect flavoprotein fluorescence in the eye, indicating mitochondrial oxidative stress. This technique may predict glaucoma progression earlier than current methods, with similar sensitivity to visual field changes.
A new study found that Black patients are six times more likely to have advanced vision loss after a glaucoma diagnosis, highlighting the need for early eye screening in this population. The research analyzed nearly 210,000 participants and used artificial intelligence to identify visual field loss patterns.
Hospitalized COVID-19 patients with high blood viscosity have a 60% higher death rate than those with low blood viscosity. The study suggests that checking for blood viscosity early on could help determine the best treatment course and improve outcomes.
The Mount Sinai Hospital has been awarded $4.2 million over five years to establish a Proteogenomic Data Analysis Center, which will help identify potential biomarkers and drug targets for cancer and new insights into cancer biology.
A study found that patients with a specific form of age-related macular degeneration are at significant risk for cardiovascular disease and stroke. Researchers discovered a strong association between the disorder's subretinal drusenoid deposits and high-risk vascular diseases.
The study found that patients with severe stress-induced myocardial ischemia are likely to benefit from heart bypass surgery or angioplasty, while those with mild or no ischemia are not. Early revascularization was associated with a more than 30 percent reduction in mortality compared to patients treated with medication.
A new Mount Sinai study reveals that young Black adults are twice as likely to have atherosclerosis as their Hispanic counterparts. Researchers used comprehensive questionnaires and 3D vascular ultrasounds to determine cardiovascular risk scores, finding significant discrepancies between the groups.
A comprehensive study found that prenatal exposure to endocrine-disrupting chemicals is associated with non-alcoholic fatty liver disease in children. The researchers measured 45 chemicals in pregnant women and found elevated levels of biomarkers indicating risk for liver disease in children who were more highly exposed.
Researchers have discovered llama-derived immune particles that provide strong protection against a vast array of SARS-like viruses, including COVID-19. These 'super-immunity' molecules, known as nanobodies, could be used to develop a fast-acting, inhalable antiviral treatment or spray.
A new study found that exposure to air pollution and indoor burning without ventilation significantly increases the risk of heart disease mortality. Researchers created maps of eight environmental risk factors across Golestan Province, Iran, and identified associations between death and these factors, controlling for traditional risk f...
Researchers from Mount Sinai found a significant connection between the immune system and amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. The study analyzed mice and human samples using state-of-the-art technologies, revealing peculiar immune signatures that distinguish different forms of ALS.
Researchers identified a three-gene signature in multiple myeloma tumors that predicts a positive response to selinexor-based therapy. The discovery could improve patient selection for targeted agents and expand the use of the drug into patients who haven't failed other therapies.
Researchers developed a rapid blood assay that measures the magnitude and duration of immunity to SARS-CoV-2, allowing large-scale monitoring of population immunity. The test takes less than 24 hours to perform and is scalable to use broadly in the population.
A new study from Mount Sinai Heart found that heart failure patients unvaccinated against COVID-19 are three times more likely to die from it than those who are fully vaccinated and boosted. The research also shows that these unvaccinated patients face higher risks of hospitalization and ICU admission if infected with the virus.
Researchers validated a liquid biopsy test as a better predictor of immunotherapy response in lung cancer patients compared to traditional tumor biopsies. The test measures the PD-L1 biomarker in blood, showing improved accuracy in predicting treatment outcomes and survival.
Researchers developed an in vitro stem cell model to map disease risk variants in human neurons, which could provide insights into the biological mechanisms underlying neuropsychiatric disorders. The study focuses on mapping cis-regulatory elements linked to psychiatric disease heritability.
This study shows how specific brain regions control the immune response during acute stress, highlighting the detrimental effect on fighting off infection. Researchers found that acute stress prompts a major migration of immune cells, diminishing an immune response to viruses like COVID-19 and influenza.
The Mount Sinai Hospital will recruit eight postdoctoral trainees for a five-year fellowship program in emergency care research. The program aims to investigate complex medical questions and lead to studies transforming patient care.
The Mount Sinai Microbiome Lab will use advanced methods to study the microbiome's role in autoimmune diseases such as rheumatoid arthritis and systemic lupus. The lab aims to identify microbial features that can help find more precise matches between diseases and treatments.
Researchers found signs of concussions and head trauma in the brains of deceased headbutting muskoxen and bighorn sheep. The study provides insights into human injuries and opens the possibility that studying these animals could help researchers understand and reduce traumatic brain injuries.
A cohort study of nearly 1,000 pregnant persons in NYC found that neighborhoods most affected by racism and economic inequality had higher rates of COVID-19 infection and preterm births. The researchers linked structural racism and community unemployment to increased risk of preterm birth.
Research at Mount Sinai Hospital found a significant difference in the prevalence of occult hypoxemia among Black, Hispanic, and White patients undergoing anesthesia. The study showed that Black and Hispanic patients experienced higher rates of unrecognized low oxygen levels despite normal pulse oximeter values.
Scientists have identified a retinoic acid-dependent hemogenic endothelial progenitor from human pluripotent stem cells, enabling the development of transcriptionally similar cells in tissue culture. This breakthrough method brings researchers closer to developing blood-forming stem cells for transfusions and cancer treatments.
Researchers at Mount Sinai have discovered a previously unknown mechanism by which not-yet-malignant breast cancer cells can travel to other organs and 'turn on' to become metastatic. The study identified potential diagnostic biomarkers, including the transcription factor NR2F1, that could help predict relapse.
Researchers at Mount Sinai have developed a reproducible method to advance the maturation of human pluripotent stem cell-derived cardiomyocytes, which support heart muscle contraction. The new protocol enables efficient energy generation from both carbohydrates and fatty acids, improving disease modeling and regenerative therapies.
Researchers have identified a gene mutation in ARID2 that signals the development of aggressively metastatic melanoma. The study suggests patients with this mutation may require different treatment approaches to manage their cancer effectively. Further research is underway to refine this understanding and improve patient outcomes.